Eurofins-Optimed, a worldwide leader in early clinical trials, announced the opening of its Boston-area office, located in the Cambridge Innovation Center (CIC) in Cambridge, Massachusetts.
Eurofins-Optimed is the Clinical Competence Center of Eurofins Group, a global leader in BioPharmaceutical product testing. The company now expects to leverage the tremendous resources of its global network in Europe, the US, and Asia to benefit biotech, pharma, and agrofood clients in the Boston area.
“As a leader in early clinical development of new drugs, Eurofins-Optimed offers a complete range of services to the pharmaceutical, biotech and medtech companies for almost 30 years” said Dr Yves Donazzolo, President and Medical Director of Eurofins-Optimed. “Our presence in Massachusetts is an exciting opportunity to expand our services and to help our clients to develop their new products by taking advantage of the stunning GXP capabilities of Eurofins services all over the world”.
“With our new presence in Cambridge, we will be able to focus on the immediate ‘early clinical trial’ needs for client companies. Our services are entirely customer configurable. Our regulatory expertise will help save our customer time and money while positioning their products for commercialization in a broad range of markets,” said Anke Kreisher, Eurofins-Optimed’s business development executive who will be based at the new office.